Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome

R Letestu, N Vitrat, A Massé… - Blood, The Journal …, 2000 - ashpublications.org
R Letestu, N Vitrat, A Massé, JPL Couedic, V Lazar, P Rameau, F Wendling, J Vuillier…
Blood, The Journal of the American Society of Hematology, 2000ashpublications.org
The thrombocytopenia and absent radii (TAR) syndrome is a rare disease associating
bilateral radial agenesis and congenital thrombocytopenia. Here, we investigated in vitro
megakaryocyte (MK) differentiation and expression of c-mpl in 6 patients. Using blood or
marrow CD34+ cells, the colony-forming unit (CFU)-MK number was markedly reduced.
CD34+ cells were also cultured in liquid medium in the presence of a combination of 3
cytokines (stem cell factor, interleukin-3, and interleukin-6) or megakaryocyte growth and …
The thrombocytopenia and absent radii (TAR) syndrome is a rare disease associating bilateral radial agenesis and congenital thrombocytopenia. Here, we investigated in vitro megakaryocyte (MK) differentiation and expression of c-mpl in 6 patients. Using blood or marrow CD34+ cells, the colony-forming unit (CFU)-MK number was markedly reduced. CD34+ cells were also cultured in liquid medium in the presence of a combination of 3 cytokines (stem cell factor, interleukin-3, and interleukin-6) or megakaryocyte growth and development factor (PEG-rHuMGDF) with or without SCF. In the presence of PEG-rHuMGDF, the majority of mature megakaryocytes (CD41 high, CD42 high) underwent apoptosis. This phenomenon was also observed in cultures stimulated by three cytokines. However, this last combination of cytokines allowed a more complete terminal MK differentiation. Surprisingly, a homogeneous population of CD34-CD41+CD42- cells accumulated during the cultures. This population was unable to differentiate along the myeloid pathways. This result suggests that a fraction of MK cells is unable to differentiate in the TAR syndrome. We subsequently investigated whether this could be related to an abnormality in c-mpl. No mutation or rearrangement in the c-mpl gene was found by Southern blots or by sequencing of the c-mpl coding region and its promoter in any of the patients. Using Western blot analysis, a decreased level of Mpl was found in patient platelets. A decreased level of c-mpl messenger RNA in TAR platelets was also detected with a lower c-mpl-P to c-mpl-K ratio in comparison to adult platelets. Altogether, these results demonstrate that the thrombocytopenia of the TAR syndrome is associated with a dysmegakaryocytopoiesis characterized by cells blocked at an early stage of differentiation.
ashpublications.org